Dr. Douglas S. Reintgen, M.D. Surgery - Surgical Oncology Medicare: Accepting Medicare Assignments Practice Location: 1501 S Pinellas Ave, Ste T, Tarpon Springs, FL 34689 Phone: 727-934-6797 Fax: 727-942-6503 |
Victor L Dragon, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 1501 S Pinellas Ave, Suite T, Tarpon Springs, FL 34689 Phone: 727-934-6796 Fax: 727-942-6503 |
News Archive
The Council on Foreign Relations recently released a new report titled, "The New Global Health Agenda: Universal Health Coverage," in which "authors Oren Ahoobim, Daniel Altman, Laurie Garrett, Vicky Hausman, and Yanzhong Huang discuss a rise in support for universal health coverage and the financial benefits that may be reaped by implementing such schemes, and provide examples of models used to date by countries in establishing universal health coverage," according to the report summary.
A cancer diagnosis is not necessarily a death sentence. There are now quite a number of possibilities to treat cancer. In addition to radiotherapy and chemotherapy, so-called radionuclide treatment has also become an important component in the fight against the mutated cells. It involves injecting radioactive elements, so-called nuclides, into the patient's circulatory system.
Scientists at the Children's Hospital of Eastern Ontario (CHEO) Research Institute have discovered a cellular pathway that is responsible for keeping blood sugar levels low in obese or pre-diabetic people, and may prevent the onset of Type 2 diabetes.
University of Toronto researchers have developed a method that can rapidly screen human stem cells and better control what they will turn into. The technology could have potential use in regenerative medicine and drug development. Findings are published in this week's issue of the journal Nature Methods.
TargeGen, Inc., a privately held biotechnology company focused on the development of small molecule kinase inhibitors today announced that the Company has agreed to be acquired by sanofi-aventis. Under the agreement, the ultimate purchase price will depend on the achievement of certain future milestones events and will total $560M if such milestones are fully realized. The closing of the transaction is expected to occur in the 3rd quarter of 2010.
› Verified 3 days ago